Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors

Clinical Cancer Research

Volumn 5, Issue 4, 1999, Pages 891-897

  Li, Chun ^a   Price, Janet E ^a   Milas, Luka ^a   Hunter, Nancy R ^a   Ke, Shi ^a   Yu, Dong Fang ^a   Charnsangavej, Chusilp ^a   Wallace, Sidney ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; PACLITAXEL DERIVATIVE; POLYGLUTAMIC ACID PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DRUG EVALUATION, PRECLINICAL; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C3H; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PACLITAXEL; POLYGLUTAMIC ACID; SARCOMA, EXPERIMENTAL; TAXOIDS; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032962184     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Holmes, F. A., Kudelka, A. P., Kavanagh, J. J., Huber, M. H., Ajani, J. A., and Valero, V. Current status of clinical trials with Taxol and docetaxel. In: G. I. Georg, T. T. Chen, I. Ojima, and D. M. Vyas (eds.), Taxane Anticancer Agents: Basic Science and Current Status, pp. 31-57. Washington, DC: American Chemical Society, 1995.
2. Rowinsky, E. K. A., and Donehower, R. C. Paclitaxel (Taxol) [Review]. N. Engl. J. Med., 332: 1004-1014, 1995.
3. Goldspiel, B. R. Paclitaxel pharmaceutical issues: preparation, administration, stability, and compatibility with other medications. Ann. Pharmacother., 28: S23-S26, 1994.
4. Dorr, R. T. Pharmacology and toxicology of Cremophor EL diluent. Ann. Pharmacother., 28: S11-S14, 1994.
5. Weiss, R. B., Donehower, R. C., Wiernick, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., and Leyland-Jones, B. Hypersensitivity reactions from paclitaxel. J. Clin. Oncol., 8: 1263-1268, 1990.
6. Maeda, H., Seymour, L. W., and Miyamoto, Y. Conjugates of anti-cancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug. Chem., 3: 351-362, 1992.
7. Li, C., Yu, D-F., Newman, R. A., Cabral, F., Stephens, L. C., Milas, L., and Wallace, S. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res., 58: 2404-2409, 1998.
8. Miltross, C. G., Mason, K. A., Hunter, N. R., Chung, W-K., Peters, L. J.. and Milas, L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J. Natl. Cancer Inst., 88: 1308-1314, 1996.
9. Milas, L., Hunter, N. R., Mason, K. A., Kurdoglu, B., and Peters, L. J. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res., 54: 3506-3510, 1994.
10. Yu, D. H., Wolf, S. K., Scanlon, M., Price, J. E., and Hung, M. C. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by Ela. Cancer Res., 53: 891-898, 1993.
11. Berchuck, A., Kamel, A., Whitaker, R., Kerns, B., Olt, G., Kinney, R., Soper, J. T., Dodge, R., Clarke-Pearson, D. L., Marks. P., McKenzie, S., Yin, S., and Bast, R. C. J. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res., 50: 4087-4091, 1990.
12. Zhang, L., Chang, C-J., Bacus, S. S., and Hung, M. C. Suppressed transformation and induced differentiation of HER-2/neu overexpressing breast cancer cells by emodin. Cancer Res., 55: 3890-3896, 1995.
13. Yu, D. H., Liu, B. L., Tan, M., and Li. J. Z. Overexpression of c-erB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Oncogene, 13: 1359-1365, 1996.
14. Price, J. E., Polyzoz, A., Zhang, R. D., and Daniels. L. M. Tumorigenicity and metastasis of human breast carcinoma lines in nude mice. Cancer Res., 50: 717-721, 1990.
15. Price, J. E., and Zhang, R. D. Studies of human breast cancer metastasis using nude mice. Cancer Metastasis Rev., 8: 285-297, 1990.